INBX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inhibrx Biosciences Inc (INBX) is not a good buy for a beginner, long-term investor at this time. The stock shows no strong positive catalysts, weak financial performance, and neutral trading sentiment. Additionally, technical indicators do not suggest a strong entry point, and there are no recent AI Stock Picker or SwingMax signals to support a buy decision.
The MACD histogram is negative (-0.271) and contracting, indicating bearish momentum. RSI is neutral at 45.542, and moving averages are converging, showing no clear trend. The price is below the pivot level (66.3), with key support at 61.441 and resistance at 71.159.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The company reported a 100% YoY revenue decline in Q4 2025, with net income and EPS also significantly down (-31.40% and -31.72% YoY, respectively). Technical indicators and candlestick patterns suggest a potential short-term decline in price (-2.03% next day, -1.86% next week).
In the latest quarter (Q4 2025), revenue dropped to 0 (-100% YoY), net income fell to -$32.83M (-31.40% YoY), and EPS decreased to -2.11 (-31.72% YoY). Gross margin remained at 100%, showing no change.
No recent analyst ratings or price target changes available.
